An Unexpected Role for the Brain’s Immune Cells

In the new study, Akassoglou and her team show that microglia (yellow) extend their branches to touch nearby neurons (blue and green), preventing these neurons from becoming overly active and causing seizures. Video by Keun-Young Kim, Gladstone Institutes. To read full article, click here.

Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

Andrew Mendiola, PhD named 2020 Berkelhammer Scholar

Unlocking the Drivers of Neuroinflammation in Neurodegenerative Disease

To read full article, click here.

Illustration of amyloid plaques on a nerverticale cell.

MS researcher gets it in gear

Andrew Mendiola, PhD featured in Momentum, the official magazine of the National MS Society

Revealing the genetic signature of neurodegenerative disease

To read full article, click here.

Scientists Build Map of Toxic Immune Cells Contributing to Neurodegeneration in MS

To read full article, click here.

‘Tox-seq’ atlas of immune cells identified for neurodegenerative therapies

Click here to read full article.

Toxic Cell Atlas Guides New Therapies for Neurodegeneration

October 31, 2019

Click here to read the full article.

Gladstone researchers Jae Kyu Ryu, Katerina Akassoglou, and Andrew Mendiola developed a novel method to profile toxic immune cells in the brain, and used it to identify a therapeutic target for multiple sclerosis.

Tox-seq revealed subtypes of brain immune cells that produce toxic reactive oxygen in a mouse model of MS.

Mark Petersen – UCSF New Frontier Research ( NFR) Award Recipient

Dr. Petersen has not only been promoted to Associate Professor at the Department of Pediatrics at UCSF; he is also the recipient of the UCSF New Frontier Research pilot award to expand his studies on ACVR1 in neurological diseases.

The New Frontier Research (NFR) is part of the UCSF Sandler Program for Breakthrough Biomedical Research designed to further biomedical discoveries, encourage new areas of exploration , and support emerging talent.